Breast cancer is divided into various subtypes on the basis of the expression status of human epidermal growth factor receptor 2 (HER2) and of estrogen (ER) and progesterone (PR) receptors by immunohistochemical staining or gene expression profiles [5, 6]. The gene discussed is ERBB2; the disease is breast cancer.